AARDVARK THERAPEUTICS, INC. (AARD) Free cash flow 2024–2025
AARDVARK THERAPEUTICS, INC. (AARD) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$54.3MFY2025 · since FY2024: -$18.2M → -$54.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$54.3M | -198.2% |
| FY2024 | -$18.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More AARD financial trends
AARD RevenueAARD Net incomeAARD Net marginAARD Gross profitAARD Gross marginAARD Operating incomeAARD Operating marginAARD Operating cash flowAARD Capital expendituresAARD Return on equityAARD Stock buybacksAARD Dividends paidAARD Total assetsAARD Total liabilitiesAARD Shareholders’ equityAARD overview →